While cardiometabolic risk factors can be used to stratify patients in terms of their vulnerability to COVID-19, our data do not provide consistent support that the expression of ACE2 or TMPRSS2 represents causal mechanisms underlying these associations. This evidence concerns the gene TMPRSS2 and COVID-19.